JAMA Oncology Author Interviews

This show features author-led interviews with leading cancer researchers, providing PR-friendly access to credible, science-backed insights. Booking a guest with a fresh JAMA Oncology article offers thought leadership, media-ready soundbites, and cross-channel opportunities for visibility in the oncology and medical communities.

127 episodes, Irregular, 3.9 rating

<1k, Male, USA

YouTube: 235.0k subscribers, Instagram: 146.0k followers

jamaonc@jamanetwork.org, support@jamanetwork.org

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Vivek Subbiah, MD

Medicine, Health & Fitness, Science

MD, PhD or equivalent clinical/research credentials; authors of JAMA Oncology articles

peer-reviewed publications, leadership in oncology research, speaking engagements, notable awards

Jiyoung Ahn, PhD - Oral Microbiome And Cancer Risk, Eduardo Bruera, MD - Proportional Sedation For Persistent Agitated Delirium In Palliative Care, David Hui, MD - Proportional Sedation For Persistent Agitated Delirium In Palliative Care, Ola Landgren, MD, PhD - New Definition Of Light Chain Monoclonal Gammopathy Of Undetermined Significance, Thorir Einarsson Long, MD, PhD - New Definition Of Light Chain Monoclonal Gammopathy Of Undetermined Significance

oncology, cancer research, clinical trials, palliative care, immunotherapy, brain metastases, leukemia, aging in cancer, kidney injury, monoclonal gammopathy